Core Viewpoint - Adeia (ADEA) shows potential for significant upside, with a mean price target of $17.33 indicating a 37% increase from its current price of $12.65 [1] Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $0.58, suggesting a consensus among analysts [2] - The lowest estimate of $17 indicates a 34.4% increase, while the highest estimate suggests a 42.3% increase to $18 [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about ADEA's earnings prospects, with a positive trend in earnings estimate revisions [11] - Over the last 30 days, one estimate has increased, leading to a 1% rise in the Zacks Consensus Estimate [12] - ADEA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should treat price targets with skepticism and not rely solely on them for investment decisions [10]

Group 1 - Consensus Cloud Solutions, Inc. (CCSI) closed at $21.37, with a 10.2% gain over the past four weeks, and a mean price target of $27.40 indicating a 28.2% upside potential [1] - The average price targets range from a low of $20 to a high of $37, with a standard deviation of $7.06, suggesting variability in analyst estimates [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 0.4% over the past month, with two estimates going higher and no negative revisions [12] - CCSI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of potential gains, the implied direction of price movement appears to be a good guide [13]

Copa Holdings (CPA) closed the last trading session at $106.47, gaining 17.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $152.73 indicates a 43.5% upside potential.The average comprises 11 short-term price targets ranging from a low of $125 to a high of $190, with a standard deviation of $19.78. While the lowest estimate indicates an increase of 17.4% from the current price le ...

Core Viewpoint - Priority Technology (PRTH) shows potential for significant upside, with a mean price target of $12.80 indicating a 67.1% increase from the current price of $7.66 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $2.77, indicating variability among analysts [2] - The lowest estimate of $10 suggests a 30.6% increase, while the highest estimate predicts a surge of 108.9% to $16 [2] - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism regarding PRTH's earnings prospects, with a strong consensus in revising EPS estimates higher [11] - The Zacks Consensus Estimate for the current year has risen by 1.9% over the past month, with one estimate increasing and no negative revisions [12] - PRTH holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13]

Core Viewpoint - Braze, Inc. (BRZE) shows significant potential for upside, with a mean price target of $50.16 indicating a 44.4% increase from its current trading price of $34.73 [1] Price Targets and Estimates - The mean estimate consists of 19 short-term price targets with a standard deviation of $9.15, suggesting variability in analyst predictions. The lowest estimate of $38 indicates a 9.4% increase, while the highest target of $75 suggests a potential surge of 116% [2] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism about BRZE's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the past 30 days, one estimate has increased, leading to a 0.7% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - BRZE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside in the near term [13]

Core Viewpoint - Si-Bone (SIBN) shares have increased by 27.6% in the past four weeks, closing at $18.38, with a mean price target of $24.67 indicating a potential upside of 34.2% [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $3.57, where the lowest estimate is $19 (3.4% increase) and the highest is $32 (74.1% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts are optimistic about SIBN's earnings prospects, as indicated by a positive trend in earnings estimate revisions, with five estimates moving higher and no negative revisions in the last 30 days, resulting in a 7.7% increase in the Zacks Consensus Estimate [11][12] - SIBN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Core Viewpoint - Vigil Neuroscience, Inc. (VIGL) has seen a significant stock price increase of 340.2% over the past four weeks, closing at $7.88, with a potential upside indicated by Wall Street analysts' mean price target of $14.71, suggesting an 86.7% increase from the current price [1] Price Targets and Analyst Estimates - The mean price target is based on seven short-term estimates with a standard deviation of $4.75, indicating variability among analysts; the lowest estimate is $8 (1.5% increase), while the highest is $22 (179.2% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about VIGL's earnings prospects, with a strong consensus on higher EPS estimates, which correlates with potential stock price increases [11] - Over the last 30 days, three earnings estimates have been revised upward, leading to a 6.9% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - VIGL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside in the near term [13]

Group 1: Stock Performance and Price Targets - Shares of Five9 (FIVN) have increased by 9.5% over the past four weeks, closing at $26.96, with a mean price target of $37.05 indicating a potential upside of 37.4% [1] - The average of 20 short-term price targets ranges from a low of $23 to a high of $65, with a standard deviation of $9.91, suggesting variability in analyst estimates [2] - The lowest estimate indicates a decline of 14.7% from the current price, while the most optimistic estimate suggests a 141.1% upside [2] Group 2: Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising earnings estimates higher, which is a positive indicator for potential stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 47.7% over the past month, with 11 estimates going higher and no negative revisions [12] - FIVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Core Viewpoint - Waystar Holding (WAY) has seen a 2.5% increase in share price over the past four weeks, closing at $38.20, with analysts suggesting a potential upside to a mean price target of $48.60, indicating a 27.2% increase from the current price [1] Price Targets and Analyst Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $2.46, where the lowest estimate of $45 suggests a 17.8% increase, and the highest estimate of $52 indicates a 36.1% increase [2] - A low standard deviation among price targets suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about WAY's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, six earnings estimates for WAY have been revised upward, resulting in a 6.1% increase in the Zacks Consensus Estimate [12] - WAY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside [13]

Group 1 - Upbound Group (UPBD) shares have increased by 16% in the past four weeks, closing at $23.66, with a mean price target of $36.63 indicating a potential upside of 54.8% [1] - The mean estimate consists of eight short-term price targets with a standard deviation of $8.07, where the lowest estimate is $26 (9.9% increase) and the highest is $50 (111.3% increase) [2] - Analysts show strong agreement in revising UPBD's earnings estimates higher, which correlates with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for UPBD's current year has risen by 1.7% over the past month, with three estimates increasing and no negative revisions [12] - UPBD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact stock gains, they can indicate the direction of price movement [13]